Delivery Order 36F79721D0249-36C25226F0447
Award Date 9/11/26
Potential Completion Date 9/30/26
Potential Value $85K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 8 issued a $183,902.60 delivery order to CSL Behring L.L.C. on July 29, 2026, for 3,000 units per vial of HAEGARDA (C1 inhibitor injection solution) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The order is issued under GSA's multiple-award Federal Supply Schedule for pharmaceuticals and drugs, with a parent ceiling of $201.48 million valid through September 29, 2026. Place of performance is King of Prussia, Pennsylvania, where CSL Behring...
- The Department of Veterans Affairs Veterans Health Administration (VA) awarded a $103,256.12 firm fixed price delivery order to CSL Behring L.L.C. for the supply of HAEGARDA, a C1 inhibitor (human) injection solution, to the VA's Veterans Integrated Service Network 8. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule (FSS) contract with the General Services Administration and the VA. The order has a completion date of December 31, 2018 and did not have...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA - VHA) awarded CSL Behring L.L.C. a $380,625.84 delivery order under the company's Pharmaceuticals and Drugs (FSS-61-IB) master contract on the General Services Administration (GSA) Multiple Award Schedule. The order is for HAEGARDA C1 INHIBITORS 3000 UNITS to be provided from CSL Behring L.L.C.'s place of performance in King of Prussia, Pennsylvania under firm fixed pricing from October...
- The Department of Veterans Affairs, Veterans Health Administration, Veterans Integrated Service Network 8 awarded a $160,099.97 firm fixed price delivery order to CSL Behring L.L.C., a global biotherapeutics company, for emergency pharmacy services. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract managed by the General Services Administration, which allows customer agencies to efficiently procure pharmaceuticals through task orders. The...
- The Department of Veterans Affairs Veterans Health Administration, through its Veterans Integrated Service Network 22, awarded a $153,282.20 firm fixed-price delivery order to CSL Behring L.L.C. for the Hereditary Angioedema treatment HAEGARDA. This order was placed against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, which allows federal agencies to efficiently procure pharmaceuticals through task orders. The contract has...
- CSL Behring L.L.C. was awarded a $52,774.08 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The delivery order is for HAEGARDA vials, with an October 24, 2022 completion date. The contract has no set-aside designation and utilizes firm fixed pricing. The place of performance is King of Prussia, Pennsylvania, and the delivery order was awarded on...
- CSL Behring L.L.C. was awarded a $193,504.96 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order is for the emergency delivery of Haegarda vaccines to the place of performance in King of Prussia, Pennsylvania, with completion required by September 30, 2022. No set-aside designation was applied to this award made under the...
- CSL Behring L.L.C. was awarded a $58,635.84 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The firm fixed price order is for the delivery of HAEGARDA vials to the place of performance in King of Prussia, Pennsylvania, with completion scheduled for June 19, 2022. No set-aside designation was applied to this order, which was awarded on June 14, 2022...
- CSL Behring L.L.C. was awarded a $226,563 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order is for the emergency medication Haegarda to be delivered to a location in King of Prussia, Pennsylvania by June 30, 2023. Associated with GSA Schedule FSS-61-IB but having no set aside designation, this order will provide a critical drug to...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order to CSL Behring L.L.C., doing business as CSL Behring LLC, for the procurement of the pharmaceutical HAEGARDA. The $152,275.80 order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration. The order is for delivery to the Phoenix VA Hospital, with performance at CSL Behring's King of Prussia, Pennsylvania...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79721D0249Federal Supply Schedule
- 36F79721D0249-36C25226F0447Delivery Order
Veterans Integrated Service Network 12 issued a $85,483.58 delivery order to CSL Behring L.L.C. on September 11, 2026, for ANDEMBRY (garadacimab-gxii) 200mg/1.2ml auto-injector, with performance completion by September 30, 2026. The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA multiple-award schedule with a $201.48 million ceiling through September 29, 2026, supporting specialty pharmaceutical procurement across the Veterans Health Administration. Place of performance is King of Prussia, PA, where CSL Behring manufactures and distributes the product. Pricing is firm fixed price with no set-aside applied.
Generated 9/12/26, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $85.5k | 9/11/26 |